Direct-to-Consumer Genetic Testing Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Test Type (Nutrigenomics Testing, Predictive Testing, Carrier Testing, and Others), Technology (Whole Genome Sequencing, Single Nucleotide Polymorphism Chips, Targeted Analysis, and Others), Distribution Channel (Online and Offline), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
The direct-to-consumer genetic testing market size is estimated to reach US$ 1.715 billion in 2022 to US$ 7.191 billion by 2030; the market is projected to record a CAGR of 19.6% from 2022 to 2030.
Some of the key driving factors for the direct-to-consumer genetic testing market growth are the growing incidence of genetic disorders and increasing awareness about the potential benefits of genetic testing drive the market. Whereas the high cost and privacy concerns associated with direct-to-consumer genetic testing hamper market growth.
Increasing Awareness About Potential Benefits of Genetic Testing
Consumers are increasingly driven by self-curiosity and empowerment, reflected by increased awareness of services that offer genetic testing and follow-up counseling. Awareness and acceptance of genetic testing are steadily increasing among the population worldwide. The shift from passive to empowered and self-aware customers is driving the genetic testing market. The inherent accessibility of direct-to-consumer genetic testing (DTC-GT) is a major advantage, giving consumers free access to their genetic information and personalized insights and recommendations. Many industries are seeing a significant increase in customers seeking tailored products and experiences, with an increased willingness to pay to identify and meet individual needs.
Genetic testing plays an important role in addressing the increasing burden of various diseases, such as diabetes and certain cancers, by eliminating the need for unnecessary examinations and screening tests and pointing the person to the best available options for prevention, treatment, and monitoring of the condition. The role of genetic testing in all areas of medicine is rapidly increasing. Genetic testing is already speeding up diagnoses, and it aids in identifying people with a genetic predisposition to highly resilient diseases. Preconception and prenatal genetic testing assist potential patients with reproductive decisions by informing them of their carrier status for genetic disorders.
The increasing awareness of the importance of genetic variations across a wide range of phenotypes associated with different diseases is further expected to promote market growth. These tests reveal whether a person has a genetic predisposition to a particular disease or phenotype of concern, which can be diagnosed as early as possible to initiate the disease treatment. The first sequencing of the human genome and developmets in genome sequencing technology is enabling rapid growth in genomics research. This has also led to direct-to-consumer genetic testing becoming a new service. The global direct-to-consumer genetic testing market has influenced many people as these tests provide valid information about various health risks, personal characteristics, and overall well-being. Further, the rapid transition of the clinical laboratory workforce to DTC-GT is another crucial factor driving the market. For example, according to MIT Technology Review, approximately 8%, or nearly 26 million, people in the US took DNA tests in 2019. That number is expected to rise to over 100 million in the coming years.
Thus, the growing awareness among the population regarding genetic testing drives the direct-to-consumer genetic testing market.
Direct-to-Consumer Genetic Testing Market: Segmental Overview
The direct-to-consumer genetic testing market is analyzed on the test type, technology, and distribution channel. The market, by test type, is segmented into ancestry testing, nutrigenomics testing, predictive testing, carrier testing, and others. The ancestry testing segment held the largest market share in 2022, whereas the predictive testing segment is anticipated to register a higher CAGR during 2022–2030.
The market based on technology is segmented into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held a larger market share in 2022 and is estimated to register a higher CAGR during 2022–2030.
Based on the distribution channel, the direct-to-consumer genetic testing market is categorized into online and offline. In 2022, the online segment held the largest market share and is anticipated to register the highest CAGR during 2022–2030.
Direct-to-Consumer Genetic Testing Market: Geographical Overview
Based on geography, the direct-to-consumer genetic testing market is analyzed for North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. Based on regions, North America accounts for a significant market share owing to the growing prevalence of genetic diseases, high spending on research and development, product approvals by the US Food and Drug Administration (FDA), and technological advances. The growing healthcare business sector and the increase in use of direct-to-consumer genetic testing will continue to offer growth opportunities for market in the region during the forecast period. Further, the rising support from government to address growing concerns about genetic diseases favors North America's direct-to-consumer genetic testing market progress. US held the largest market share in the North America direct-to-consumer genetic testing market. The FDA approved 23andMe's DTC genetic test in 2022 for a hereditary prostate cancer marker. Direct-to-consumer genetic testing has been gaining significant popularity in the US. According to the US National Institutes of Health (NIH), DTC genetic tests are marketed directly to consumers via television, print advertising, or the Internet. Thus, the increasing prevalence of genetic disorders, coupled with the rising adoption of advanced gene therapies to treat chronic diseases, drives the market in the US.
Moreover, Asia Pacific region is expected to witness fastest growth rate during the forecast period. The proliferation of the direct-to-consumer genetic testing market in Asia Pacific is attributed to the increasing need for superior treatment solutions, a rise in awareness of the early screening of genetic disorders, and the growing focus on research and development activities. Additionally, an upsurge in the R&D for genomics, a large pool of patients, and upgrades in healthcare infrastructure are projected to favor the growth of the direct-to-consumer genetic testing market in Asia Pacific during the forecast period.
Moreover, Europe held the second largest market share in the global direct-to-consumer genetic testing market. The regional market is expected to grow significantly in the coming years owing to the rising awareness regarding genetic tests and the rising prevalence of genetic disorders and cancer. Germany held the largest market share in the European direct-to-consumer genetic testing market, whereas the UK is expected to witness the fastest growth during the forecast period.
The rising technological advancements in the past few years have opened numerous opportunities for the direct-to-consumer genetic testing market expansion. The development of customized testing kits for niche therapeutic areas and the rising prevalence of chronic diseases benefit the direct-to-consumer genetic testing market in Germany.
Direct-to-Consumer Genetic Testing Market: Key Players
Under the direct-to-consumer genetic testing market study, a few key players were analyzed, which include Genesis Healthcare Co, Ancestry Genomics Inc, Color Health Inc, Helix Inc, Myriad Genetics, Inc, Living DNA Ltd, 23andMe Inc, Genetic Technologies Ltd, Gene By Gene Ltd, and Full Genomes Corp Inc.
A few of the key primary and secondary sources referred to while preparing the report on the direct-to-consumer genetic testing market are the World Health Organization (WHO), FDA (Food and Drug Administration), UK Genetic Testing Network, and French National Authority for Health, and National Institutes of Health
Some of the key driving factors for the direct-to-consumer genetic testing market growth are the growing incidence of genetic disorders and increasing awareness about the potential benefits of genetic testing drive the market. Whereas the high cost and privacy concerns associated with direct-to-consumer genetic testing hamper market growth.
Increasing Awareness About Potential Benefits of Genetic Testing
Consumers are increasingly driven by self-curiosity and empowerment, reflected by increased awareness of services that offer genetic testing and follow-up counseling. Awareness and acceptance of genetic testing are steadily increasing among the population worldwide. The shift from passive to empowered and self-aware customers is driving the genetic testing market. The inherent accessibility of direct-to-consumer genetic testing (DTC-GT) is a major advantage, giving consumers free access to their genetic information and personalized insights and recommendations. Many industries are seeing a significant increase in customers seeking tailored products and experiences, with an increased willingness to pay to identify and meet individual needs.
Genetic testing plays an important role in addressing the increasing burden of various diseases, such as diabetes and certain cancers, by eliminating the need for unnecessary examinations and screening tests and pointing the person to the best available options for prevention, treatment, and monitoring of the condition. The role of genetic testing in all areas of medicine is rapidly increasing. Genetic testing is already speeding up diagnoses, and it aids in identifying people with a genetic predisposition to highly resilient diseases. Preconception and prenatal genetic testing assist potential patients with reproductive decisions by informing them of their carrier status for genetic disorders.
The increasing awareness of the importance of genetic variations across a wide range of phenotypes associated with different diseases is further expected to promote market growth. These tests reveal whether a person has a genetic predisposition to a particular disease or phenotype of concern, which can be diagnosed as early as possible to initiate the disease treatment. The first sequencing of the human genome and developmets in genome sequencing technology is enabling rapid growth in genomics research. This has also led to direct-to-consumer genetic testing becoming a new service. The global direct-to-consumer genetic testing market has influenced many people as these tests provide valid information about various health risks, personal characteristics, and overall well-being. Further, the rapid transition of the clinical laboratory workforce to DTC-GT is another crucial factor driving the market. For example, according to MIT Technology Review, approximately 8%, or nearly 26 million, people in the US took DNA tests in 2019. That number is expected to rise to over 100 million in the coming years.
Thus, the growing awareness among the population regarding genetic testing drives the direct-to-consumer genetic testing market.
Direct-to-Consumer Genetic Testing Market: Segmental Overview
The direct-to-consumer genetic testing market is analyzed on the test type, technology, and distribution channel. The market, by test type, is segmented into ancestry testing, nutrigenomics testing, predictive testing, carrier testing, and others. The ancestry testing segment held the largest market share in 2022, whereas the predictive testing segment is anticipated to register a higher CAGR during 2022–2030.
The market based on technology is segmented into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held a larger market share in 2022 and is estimated to register a higher CAGR during 2022–2030.
Based on the distribution channel, the direct-to-consumer genetic testing market is categorized into online and offline. In 2022, the online segment held the largest market share and is anticipated to register the highest CAGR during 2022–2030.
Direct-to-Consumer Genetic Testing Market: Geographical Overview
Based on geography, the direct-to-consumer genetic testing market is analyzed for North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. Based on regions, North America accounts for a significant market share owing to the growing prevalence of genetic diseases, high spending on research and development, product approvals by the US Food and Drug Administration (FDA), and technological advances. The growing healthcare business sector and the increase in use of direct-to-consumer genetic testing will continue to offer growth opportunities for market in the region during the forecast period. Further, the rising support from government to address growing concerns about genetic diseases favors North America's direct-to-consumer genetic testing market progress. US held the largest market share in the North America direct-to-consumer genetic testing market. The FDA approved 23andMe's DTC genetic test in 2022 for a hereditary prostate cancer marker. Direct-to-consumer genetic testing has been gaining significant popularity in the US. According to the US National Institutes of Health (NIH), DTC genetic tests are marketed directly to consumers via television, print advertising, or the Internet. Thus, the increasing prevalence of genetic disorders, coupled with the rising adoption of advanced gene therapies to treat chronic diseases, drives the market in the US.
Moreover, Asia Pacific region is expected to witness fastest growth rate during the forecast period. The proliferation of the direct-to-consumer genetic testing market in Asia Pacific is attributed to the increasing need for superior treatment solutions, a rise in awareness of the early screening of genetic disorders, and the growing focus on research and development activities. Additionally, an upsurge in the R&D for genomics, a large pool of patients, and upgrades in healthcare infrastructure are projected to favor the growth of the direct-to-consumer genetic testing market in Asia Pacific during the forecast period.
Moreover, Europe held the second largest market share in the global direct-to-consumer genetic testing market. The regional market is expected to grow significantly in the coming years owing to the rising awareness regarding genetic tests and the rising prevalence of genetic disorders and cancer. Germany held the largest market share in the European direct-to-consumer genetic testing market, whereas the UK is expected to witness the fastest growth during the forecast period.
The rising technological advancements in the past few years have opened numerous opportunities for the direct-to-consumer genetic testing market expansion. The development of customized testing kits for niche therapeutic areas and the rising prevalence of chronic diseases benefit the direct-to-consumer genetic testing market in Germany.
Direct-to-Consumer Genetic Testing Market: Key Players
Under the direct-to-consumer genetic testing market study, a few key players were analyzed, which include Genesis Healthcare Co, Ancestry Genomics Inc, Color Health Inc, Helix Inc, Myriad Genetics, Inc, Living DNA Ltd, 23andMe Inc, Genetic Technologies Ltd, Gene By Gene Ltd, and Full Genomes Corp Inc.
A few of the key primary and secondary sources referred to while preparing the report on the direct-to-consumer genetic testing market are the World Health Organization (WHO), FDA (Food and Drug Administration), UK Genetic Testing Network, and French National Authority for Health, and National Institutes of Health
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. DIRECT-TO-CONSUMER GENETIC TESTING MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. DIRECT-TO-CONSUMER GENETIC TESTING MARKET - KEY INDUSTRY DYNAMICS
5.1 Market Drivers
5.1.1 Growing Incidence of Genetic Disorders
5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
5.2 Market Restraints
5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
5.3 Market Opportunities
5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
5.4 Future Trends
5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
5.5 Impact Analysis
6. DIRECT-TO-CONSUMER GENETIC TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1 Direct-To-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 – 2030
7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET – REVENUE AND FORECAST TO 2030 – BY TEST TYPE
7.1 Overview
7.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Ancestry Testing
7.3.1 Overview
7.3.2 Ancestry Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Nutrigenomics Testing
7.4.1 Overview
7.4.2 Nutrigenomics Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Predictive Testing
7.5.1 Overview
7.5.2 Predictive Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Carrier Testing
7.6.1 Overview
7.6.2 Carrier Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET – REVENUE AND FORECAST TO 2030 – BY TECHNOLOGY
8.1 Overview
8.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Whole Genome Sequencing
8.3.1 Overview
8.3.2 Whole Genome Sequencing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Single Nucleotide Polymorphism Chips
8.4.1 Overview
8.4.2 Single Nucleotide Polymorphism Chips: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Targeted Analysis
8.5.1 Overview
8.5.2 Targeted Analysis: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET – REVENUE AND FORECAST TO 2030 – BY DISTRIBUTION CHANNEL
9.1 Overview
9.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Online Platform
9.3.1 Overview
9.3.2 Online Platform: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Offline Platform
9.4.1 Overview
9.4.2 Offline Platform: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10. DIRECT-TO-CONSUMER GENETIC TESTING MARKET – REVENUE AND FORECAST TO 2030 – GEOGRAPHIC ANALYSIS
10.1 North America: Direct-To-Consumer Genetic Testing Market
10.1.1 Overview
10.1.2 North America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1 North America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.2.2 North America: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.2.3 North America: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3 North America: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.1.3.1 US: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.2 US: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.2.1 US: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.2.2 US: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.2.3 US: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3.3 Canada: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.4 Canada: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.4.1 Canada: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.4.2 Canada: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.4.3 Canada: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3.5 Mexico: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.6 Mexico: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.6.1 Mexico: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.6.2 Mexico: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.6.3 Mexico: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2 Europe: Direct-To-Consumer Genetic Testing Market
10.2.1 Overview
10.2.2 Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.2.1 Europe: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.2.2 Europe: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.2.3 Europe: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3 Europe: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.2.3.1 Germany: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.2 Germany: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.2.1 Germany: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.2.2 Germany: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.2.3 Germany: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.3 UK: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.4 UK: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.4.1 UK: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.4.2 UK: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.4.3 UK: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.5 France: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.6 France: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.6.1 France: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.6.2 France: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.6.3 France: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.7 Italy: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.8 Italy: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.8.1 Italy: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.8.2 Italy: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.8.3 Italy: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.9 Spain: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.10 Spain: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.10.1 Spain: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.10.2 Spain: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.10.3 Spain: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.11 Rest of Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.12 Rest of Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.12.1 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.12.2 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.12.3 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market
10.3.1 Overview
10.3.2 Asia Pacific: Direct-To-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
10.3.2.1 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.2.2 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.2.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.3.3.1 China: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.2 China: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.2.1 China: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.2.2 China: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.2.3 China: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.3 Japan: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.4 Japan: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.4.1 Japan: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.4.2 Japan: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.4.3 Japan: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.5 India: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.6 India: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.6.1 India: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.6.2 India: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.6.3 India: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.7 Australia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.8 Australia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.8.1 Australia: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.8.2 Australia: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.8.3 Australia: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.9 South Korea: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.10 South Korea: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.10.1 South Korea: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.10.2 South Korea: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.10.3 South Korea: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.11 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.12 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.12.1 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.12.2 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.12.3 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4 Middle East & Africa Direct-To-Consumer Genetic Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.2.1 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.2.2 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.2.3 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.4.3.1 Saudi Arabia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.2 Saudi Arabia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.2.1 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.2.2 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.2.3 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.3 South Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.4 South Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.4.1 South Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.4.2 South Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.4.3 South Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.5 UAE: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.6 UAE: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.6.1 UAE: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.6.2 UAE: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.6.3 UAE: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.7 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.8 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.8.1 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.8.2 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.8.3 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5 South & Central America: Direct-To-Consumer Genetic Testing Market
10.5.1 Overview
10.5.2 South & Central America: Direct-To-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
10.5.2.1 South & Central America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.2.2 South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.2.3 South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3 South & Central America: Direct-To-Consumer Genetic Testing Market Share by Country – 2022 & 2030, (%)
10.5.3.1 Brazil: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.2 Brazil: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.2.1 Brazil: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.2.2 Brazil: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.2.3 Brazil: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3.3 Argentina: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.4 Argentina: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.4.1 Argentina: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.4.2 Argentina: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.4.3 Argentina: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3.5 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.6 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.6.1 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.6.2 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.6.3 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
11. DIRECT-TO-CONSUMER GENETIC TESTING MARKET–INDUSTRY LANDSCAPE
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. COMPANY PROFILES
12.1 Genesis Healthcare Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Ancestry Genomics Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Color Health Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Helix Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Myriad Genetics, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Living DNA Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7andMe Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Genetic Technologies Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Gene By Gene Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Full Genomes Corp Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. DIRECT-TO-CONSUMER GENETIC TESTING MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. DIRECT-TO-CONSUMER GENETIC TESTING MARKET - KEY INDUSTRY DYNAMICS
5.1 Market Drivers
5.1.1 Growing Incidence of Genetic Disorders
5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
5.2 Market Restraints
5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
5.3 Market Opportunities
5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
5.4 Future Trends
5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
5.5 Impact Analysis
6. DIRECT-TO-CONSUMER GENETIC TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1 Direct-To-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 – 2030
7. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET – REVENUE AND FORECAST TO 2030 – BY TEST TYPE
7.1 Overview
7.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
7.3 Ancestry Testing
7.3.1 Overview
7.3.2 Ancestry Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Nutrigenomics Testing
7.4.1 Overview
7.4.2 Nutrigenomics Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Predictive Testing
7.5.1 Overview
7.5.2 Predictive Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Carrier Testing
7.6.1 Overview
7.6.2 Carrier Testing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET – REVENUE AND FORECAST TO 2030 – BY TECHNOLOGY
8.1 Overview
8.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Whole Genome Sequencing
8.3.1 Overview
8.3.2 Whole Genome Sequencing: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Single Nucleotide Polymorphism Chips
8.4.1 Overview
8.4.2 Single Nucleotide Polymorphism Chips: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Targeted Analysis
8.5.1 Overview
8.5.2 Targeted Analysis: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
9. GLOBAL DIRECT-TO-CONSUMER GENETIC TESTING MARKET – REVENUE AND FORECAST TO 2030 – BY DISTRIBUTION CHANNEL
9.1 Overview
9.2 Direct-To-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Online Platform
9.3.1 Overview
9.3.2 Online Platform: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Offline Platform
9.4.1 Overview
9.4.2 Offline Platform: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10. DIRECT-TO-CONSUMER GENETIC TESTING MARKET – REVENUE AND FORECAST TO 2030 – GEOGRAPHIC ANALYSIS
10.1 North America: Direct-To-Consumer Genetic Testing Market
10.1.1 Overview
10.1.2 North America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1 North America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.2.2 North America: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.2.3 North America: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3 North America: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.1.3.1 US: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.2 US: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.2.1 US: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.2.2 US: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.2.3 US: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3.3 Canada: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.4 Canada: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.4.1 Canada: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.4.2 Canada: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.4.3 Canada: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.3.5 Mexico: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.1.3.6 Mexico: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3.6.1 Mexico: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.1.3.6.2 Mexico: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.1.3.6.3 Mexico: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2 Europe: Direct-To-Consumer Genetic Testing Market
10.2.1 Overview
10.2.2 Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.2.1 Europe: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.2.2 Europe: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.2.3 Europe: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3 Europe: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.2.3.1 Germany: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.2 Germany: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.2.1 Germany: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.2.2 Germany: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.2.3 Germany: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.3 UK: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.4 UK: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.4.1 UK: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.4.2 UK: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.4.3 UK: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.5 France: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.6 France: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.6.1 France: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.6.2 France: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.6.3 France: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.7 Italy: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.8 Italy: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.8.1 Italy: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.8.2 Italy: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.8.3 Italy: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.9 Spain: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.10 Spain: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.10.1 Spain: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.10.2 Spain: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.10.3 Spain: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.3.11 Rest of Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.2.3.12 Rest of Europe: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3.12.1 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.2.3.12.2 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.2.3.12.3 Rest of Europe: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market
10.3.1 Overview
10.3.2 Asia Pacific: Direct-To-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
10.3.2.1 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.2.2 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.2.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3 Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.3.3.1 China: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.2 China: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.2.1 China: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.2.2 China: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.2.3 China: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.3 Japan: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.4 Japan: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.4.1 Japan: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.4.2 Japan: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.4.3 Japan: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.5 India: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.6 India: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.6.1 India: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.6.2 India: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.6.3 India: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.7 Australia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.8 Australia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.8.1 Australia: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.8.2 Australia: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.8.3 Australia: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.9 South Korea: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.10 South Korea: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.10.1 South Korea: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.10.2 South Korea: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.10.3 South Korea: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.3.11 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.3.3.12 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3.12.1 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.3.3.12.2 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.3.3.12.3 Rest of Asia Pacific: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4 Middle East & Africa Direct-To-Consumer Genetic Testing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.2.1 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.2.2 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.2.3 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3 Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Country, 2022 & 2030 (%)
10.4.3.1 Saudi Arabia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.2 Saudi Arabia: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.2.1 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.2.2 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.2.3 Saudi Arabia: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.3 South Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.4 South Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.4.1 South Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.4.2 South Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.4.3 South Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.5 UAE: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.6 UAE: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.6.1 UAE: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.6.2 UAE: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.6.3 UAE: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.3.7 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.4.3.8 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3.8.1 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.4.3.8.2 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Technology, 2020–2030 (US$ Million)
10.4.3.8.3 Rest of Middle East & Africa: Direct-To-Consumer Genetic Testing Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5 South & Central America: Direct-To-Consumer Genetic Testing Market
10.5.1 Overview
10.5.2 South & Central America: Direct-To-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
10.5.2.1 South & Central America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.2.2 South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.2.3 South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3 South & Central America: Direct-To-Consumer Genetic Testing Market Share by Country – 2022 & 2030, (%)
10.5.3.1 Brazil: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.2 Brazil: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.2.1 Brazil: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.2.2 Brazil: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.2.3 Brazil: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3.3 Argentina: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.4 Argentina: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.4.1 Argentina: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.4.2 Argentina: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.4.3 Argentina: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.3.5 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (USD Million)
10.5.3.6 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3.6.1 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, by Test Type, 2020–2030 (US$ Million)
10.5.3.6.2 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Technology, 2020–2030 (US$ Million)
10.5.3.6.3 Rest of South & Central America: Direct-To-Consumer Genetic Testing Market, By Distribution Channel, 2020–2030 (US$ Million)
11. DIRECT-TO-CONSUMER GENETIC TESTING MARKET–INDUSTRY LANDSCAPE
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. COMPANY PROFILES
12.1 Genesis Healthcare Co
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Ancestry Genomics Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Color Health Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Helix Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Myriad Genetics, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Living DNA Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7andMe Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Genetic Technologies Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Gene By Gene Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Full Genomes Corp Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About Us
13.2 Glossary of Terms
